The theory of homogeny of liver and kidney in the treatment of kidney and liver fibrosis.
10.1007/s11655-012-1063-5
- Author:
Ping LI
1
;
Hao-Jun ZHANG
;
Liu-Tao ZHENG
Author Information
1. Department of Pharmacology, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China. lp8675@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Animals;
Disease Models, Animal;
Drugs, Chinese Herbal;
pharmacology;
therapeutic use;
Humans;
Kidney;
drug effects;
pathology;
Kidney Diseases;
drug therapy;
therapy;
Liver;
drug effects;
pathology;
Liver Cirrhosis;
drug therapy;
therapy;
Models, Biological;
Rats;
Signal Transduction;
drug effects;
Transforming Growth Factor beta1;
metabolism
- From:
Chinese journal of integrative medicine
2012;18(4):250-252
- CountryChina
- Language:English
-
Abstract:
Chronic kidney disease (CKD) and chronic liver disease are both very harmful to human health almost all over the world, which lead to the fibrosis of the two organs ultimately. Currently, there are few satisfactory therapeutic methods in treating the two diseases. Some research works from Chinese medicine and Western medicine were done in the area recently, the results showed that kidney and liver fibrosis shared similar biological signals and events such as epithelial-mesenchymal transition (EMT) and transforming growth factor β 1, the same herbal mesenchymal medicine exhibited significantly improving effects on both liver fibrosis and kidney fibrosis by involving similar mechanism. This coincides with the theory of homogeny of Liver (Gan) and Kidney (Shen) of Chinese medicine. It would provides new clues in exploring the treatment of liver fibrosis and kidney fibrosis.
